Regulations and Regulatory Advocacy
CMS's Conditions of Participation as accreditation standards | Proposed rule - Learn about the proposed rule by CMS that requires accrediting organizations to use CMS's Conditions of Participation as their minimum accreditation standards. Find out how this change can align accreditation鈥
The Department of Health and Human Services鈥 Office for Civil Rights Jan. 25 released guidance reminding hospitals, critical access hospitals and long-term care facilities of their obligation under Centers for Medicare & Medicaid Services regulations to ensure that their visitation policies do鈥
The Centers for Medicare & Medicaid Services Dec. 4 released an interim final rule implementing new enforcement authorities the agency will use if states fail to comply with new reporting requirements as they restore Medicaid eligibility and enrollment operations following the end of the鈥
President Biden October 30 issued an Executive Order (EO) on the use of artificial intelligence (AI) that attempts to strike a balance between managing the risks and encouraging innovation.
The Centers for Medicare & Medicaid Services (CMS) Nov. 15 issued a final rule requiring the disclosure of ownership, managerial and other information for skilled-nursing facilities (SNFs) and nursing facilities (NFs).
The AHA strongly urges the FDA to work with Congress to enact an updated version of the Verifying Accurate Leading-Edge IVCT Development (VALID) Act. This legislation would establish a diagnostic-specific, risk-based framework that recognizes the essential role of clinical laboratories in鈥
Waivers allowed practitioners to render telehealth services from their home without having to report their home address on Medicare enrollment or claims forms. Beginning Jan. 1, 2024, these providers will be required to report their home address on enrollment and claims forms.
The Food and Drug Administration Sept. 29 released a proposed rule that would phase out over four years its general enforcement discretion approach for most laboratory developed tests, citing concern that some of the tests may not provide accurate results or perform as well as FDA-approved in vitro鈥
FDA last month approved a new long-acting monoclonal antibody to prevent RSV in this age group.
The 5th Circuit Court of Appeals should reverse the Federal Trade Commission鈥檚 decision in Illumina Inc. v. FTC, 鈥渁 paradigmatic example鈥 of how the agency鈥檚 practices violate the Constitution鈥檚 due process clause, AHA said in a friend-of-the-court brief filed in the case.